About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Oxycodone
- Procedure number
- PSUSA/00002254/202104
- Regulatory outcome
- Variation
Documents
Oxycodone : List of nationally authorised medicinal products - PSUSA/00002254/202104
English (EN) (510.16 KB - PDF)
Oxycodone : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002254/202104
English (EN) (205.51 KB - PDF)
български (BG) (292.01 KB - PDF)
español (ES) (210.22 KB - PDF)
čeština (CS) (161.83 KB - PDF)
dansk (DA) (214.08 KB - PDF)
Deutsch (DE) (242.89 KB - PDF)
eesti keel (ET) (200.93 KB - PDF)
ελληνικά (EL) (268.51 KB - PDF)
français (FR) (227.02 KB - PDF)
hrvatski (HR) (287.67 KB - PDF)
íslenska (IS) (213.35 KB - PDF)
italiano (IT) (213.47 KB - PDF)
latviešu valoda (LV) (296.66 KB - PDF)
lietuvių kalba (LT) (286.49 KB - PDF)
magyar (HU) (313.38 KB - PDF)
Malti (MT) (241.3 KB - PDF)
Nederlands (NL) (208.28 KB - PDF)
norsk (NO) (204.07 KB - PDF)
polski (PL) (247.98 KB - PDF)
português (PT) (311.01 KB - PDF)
română (RO) (390.27 KB - PDF)
slovenčina (SK) (287.18 KB - PDF)
slovenščina (SL) (284.3 KB - PDF)
Suomi (FI) (201.41 KB - PDF)
svenska (SV) (194.95 KB - PDF)